Chu D - Search Results

1

Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate.

Foster CS, Tufail F, Waheed NK, Chu D, Miserocchi E, Baltatzis S, Vredeveld CM. Foster CS, et al. Among authors: chu d. Arch Ophthalmol. 2003 Apr;121(4):437-40. doi: 10.1001/archopht.121.4.437. Arch Ophthalmol. 2003. PMID: 12695239 Clinical Trial.

2

Sympathetic ophthalmia.

Chu DS, Foster CS. Chu DS, et al. Int Ophthalmol Clin. 2002 Summer;42(3):179-85. doi: 10.1097/00004397-200207000-00019. Int Ophthalmol Clin. 2002. PMID: 12131594 Review. No abstract available.

3

Treatment of ocular inflammatory disorders with daclizumab.

Papaliodis GN, Chu D, Foster CS. Papaliodis GN, et al. Among authors: chu d. Ophthalmology. 2003 Apr;110(4):786-9. doi: 10.1016/S0161-6420(02)01932-2. Ophthalmology. 2003. PMID: 12689903 Clinical Trial.

4

Ocular manifestations and concepts of systemic vasculitides.

Perez VL, Chavala SH, Ahmed M, Chu D, Zafirakis P, Baltatzis S, Ocampo V, Foster CS. Perez VL, et al. Among authors: chu d. Surv Ophthalmol. 2004 Jul-Aug;49(4):399-418. doi: 10.1016/j.survophthal.2004.04.008. Surv Ophthalmol. 2004. PMID: 15231396 Review.

5

Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies.

Perez VL, Papaliodis GN, Chu D, Anzaar F, Christen W, Foster CS. Perez VL, et al. Among authors: chu d. Ocul Immunol Inflamm. 2004 Sep;12(3):193-201. doi: 10.1080/092739490500282. Ocul Immunol Inflamm. 2004. PMID: 15385196 Review.

6

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.

Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH; Psoriasis Study Group; Durez P, Tak PP, Gomez-Reino JJ; Rheumatoid Arthritis Study Group; Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD; Uveitis Study Group; Rose K, Haider A, Di Padova F. Hueber W, et al. Among authors: chu ds. Sci Transl Med. 2010 Oct 6;2(52):52ra72. doi: 10.1126/scitranslmed.3001107. Sci Transl Med. 2010. PMID: 20926833 Clinical Trial.

7

The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.

Foster CS, Kothari S, Anesi SD, Vitale AT, Chu D, Metzinger JL, Cerón O. Foster CS, et al. Among authors: chu d. Surv Ophthalmol. 2016 Jan-Feb;61(1):1-17. doi: 10.1016/j.survophthal.2015.07.001. Epub 2015 Jul 9. Surv Ophthalmol. 2016. PMID: 26164736 Review.

8

Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis.

Kolomeyer AM, Tu Y, Miserocchi E, Ranjan M, Davidow A, Chu DS. Kolomeyer AM, et al. Ocul Immunol Inflamm. 2016 Aug;24(4):377-85. doi: 10.3109/09273948.2015.1125509. Epub 2016 Feb 22. Ocul Immunol Inflamm. 2016. PMID: 26902465

9

Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis.

Sepah YJ, Sadiq MA, Chu DS, Dacey M, Gallemore R, Dayani P, Hanout M, Hassan M, Afridi R, Agarwal A, Halim MS, Do DV, Nguyen QD. Sepah YJ, et al. Am J Ophthalmol. 2017 Nov;183:71-80. doi: 10.1016/j.ajo.2017.08.019. Epub 2017 Sep 5. Am J Ophthalmol. 2017. PMID: 28887113 Clinical Trial.

10

Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement.

Mandell KJ, Clark D, Chu DS, Foster CS, Sheppard J, Brady TC. Mandell KJ, et al. Among authors: chu ds. J Ocul Pharmacol Ther. 2020 Dec;36(10):732-739. doi: 10.1089/jop.2020.0056. Epub 2020 Sep 22. J Ocul Pharmacol Ther. 2020. PMID: 32955967 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,509 results

Search Page